| |
|
|
|
Evofem Biosciences Inc.  
|
|
6.5 0.15 (0.02%) |
06-17 16:00 |
|
Open: |
6.34 |
Pre close: |
6.35 |
Target:
|
7.88 
|
|
High: |
6.73 |
Low: |
6.24 |
Resistance:
|
6.75
7.88
|
|
Volume: |
115,708 |
Market Cap: |
302M |
Support:
|
5.56
4.83
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.42
 |
MACD |
MACD(12,26):
|
0.40 |
|
MA(20): |
5.98 |
Signal(12,26,9): |
0.41 |
|
MA(100): |
4.28 |
Stochastic Oscillator |
%K(14,3):
|
83.35 |
|
MA(250): |
3.71 |
%D(3): |
84.34 |
|
Average Volume(K) |
3-Month: |
8903
|
52-Week |
High:
|
7.24 |
|
10-Days: |
7234 |
Low: |
1.79 |
|
RSI |
RSI(14):
|
60.75 |
Change(%): |
90.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.400 |
Return on Equity (ttm) |
328.4 |
Shares Out. (M) |
35.37 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-1308.1 |
Shares Float (M) |
34.02 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
-0.15 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-1.520 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
16.480 |
EBITDA (p.s.) |
0.000 |
P/E |
-2.71 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.39 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-46.04 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-23.47 |
P/CF |
-4.99 |
|
|
|
|
|
|
